查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2017200

注射包装市场：按容器类型、容器材料、瓶盖类型、剂型、填充量、最终用户和应用划分－2026-2032年全球市场预测

Parenteral Products Packaging Market by Container Type, Container Material, Closure Type, Dosage Form, Fill Volume, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，注射剂包装市场价值将达到 246.5 亿美元，到 2026 年将成长至 268.3 亿美元，到 2032 年将达到 479.7 亿美元，复合年增长率为 9.97%。

主要市场统计数据
基准年 2025 246.5亿美元
预计年份：2026年 268.3亿美元
预测年份 2032 479.7亿美元
复合年增长率 (%) 9.97%

本策略性介绍概述了为什么注射剂产品的包装对于整个现代治疗产品组合的产品完整性、监管合规性和供应链弹性至关重要。

注射剂包装涉及病患安全、无菌生产以及全球供应链的复杂性。本文旨在阐明为何该领域需要持续的策略关注。随着治疗方法发展为生物製药、复方製剂和高敏感性製剂，包装的功能已不再局限于简单的密封，而是成为确保产品完整性、无菌性、低温运输相容性和以用户为中心的给药方式的关键要素。因此，参与药物研发、契约製造和分销的相关人员必须协调设计控制、法规遵循流程和筹资策略，以维持治疗效果并降低污染风险。

评估近期美国关税趋势如何改变注射剂药品包装整个价值链的采购选择、成本考量和近岸外包策略。

美国关税和贸易政策调整为从世界各地采购包装组件的公司带来了新的成本、交货时间和采购的考量。为了应对这些挑战，采购团队正在重新审视其供应商策略，透过提高在地采购率、协商包含保护性条款的长期合约以及审查关税分类以确保HS编码（协调制度）的准确应用来降低关税风险。透过这些综合措施，他们可以减少意外的关税负担并简化海关程序。

详细的细分洞察揭示了容器类型、材料、封盖、剂型、填充量、使用环境和应用如何全面影响包装决策和测试要求。

对细分市场的深入理解揭示了技术要求、采购优先顺序和临床应用案例的交汇点，以及它们如何影响包装决策。根据容器类型，相关人员会评估每种配置（安瓿、袋装、药筒、注射器和管瓶）在剂量精度、与无菌填充线的兼容性以及患者给药需求方面的优缺点。同时，也需要仔细考虑玻璃和塑胶容器材料之间的差异。 PET、聚丙烯和PVC等塑胶替代品在化学相容性、耐灭菌性和阻隔性方面各有优劣。这些材料的选择必须兼顾监管要求和合格评定结果。

将美洲、欧洲、中东、非洲和亚太地区的供应链结构、法规结构和创新重点的差异进行区域比较。

区域趋势对注射剂包装的供应链结构、监管协调和创新重点有显着影响。在美洲，製造商和加工商通常优先考虑产品上市速度、生产规模以及与当地监管机构的亲和性，同时寻求区域伙伴关係关係以缩短供应链。该地区拥有成熟的医药产业丛集和先进的物流基础设施，有利于高效分销和严格的品质系统。

从企业层面深入了解供应商和製造商如何透过技术投资、整合服务和弹性伙伴关係模式来建立竞争优势。

引领注射包装生态系统的企业正透过在品质、自动化和材料科学方面的定向投资来脱颖而出，同时建立策略合作伙伴关係以弥补能力差距。注重封闭式填充和容器密封测试的供应商正在满足客户对确保无菌性的高期望。同时，致力于开发聚合物配方和表面处理技术以减少分层和萃取的公司正在高价值生物製药应用领域获得技术领先地位。

为行业领导者提供切实可行的建议，以加强整个注射剂药品包装业务的供应商合格、技术验证、扩充性和永续性。

产业领导者可以透过整合跨职能部门的优先事项，制定面向未来的包装策略，从而在创新与合蓝图之间取得平衡。首先，企业应优先考虑端到端的供应商资格认证，包括可审核的文件、材料检验协议和替代采购方案。协调品质、采购和法规遵循团队可以降低供应中断的风险，并加速纠正措施的实施。其次，投资于萃取物和洗脱液、容器和密封系统完整性以及人为因素的先进合格测试，可以降低上市风险，并支持监管申报。随着治疗方法从临床应用过渡到商业化供应，这些技术投资将带来显着成效。

本报告概述了一种透明的调查方法，描述了定性研究、技术文献和最佳实践的综合审查过程，这些内容构成了报告结论和建议的基础。

本研究采用综合分析方法，结合一手质性研究、实验方案回顾和二手技术文献，得出可操作的见解。一手研究包括与品质保证、法规和采购专家进行结构化访谈和研讨会，以识别营运挑战、供应商选择标准和商业化限制因素。这些第一线专家的观点与技术白皮书、法规指导文件以及关于材料适用性、容器和封盖系统完整性以及包装相关失效模式的同行评审研究进行交叉比对，以确保技术准确性。

该摘要概述了策略包装决策如何影响整体治疗方法的产品安全性、监管准备和供应链稳健性。

总之，注射剂包装正从一个简单的组成部分转变为影响产品可行性、监管审批和供应连续性的策略领域。材料创新、监管对安全性和合规性的重视以及不断变化的用户需求，正在重新定义产品整个生命週期中的包装要求。那些积极协调技术检验、供应商策略和营运投资的企业，更有能力降低风险，并在日益复杂的环境中实现差异化竞争优势。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：按容器类型分類的注射剂药品包装市场

  • 安瓿
  • 包包
  • 墨水匣
  • 注射器
  • 管瓶

第九章：注射剂药品包装市场（依容器材料划分）

  • 玻璃
  • 塑胶
    • PET
    • 聚丙烯
    • PVC

第十章：注射剂包装的市场关闭方法

  • 压盖
  • 翻盖式帽
  • 橡胶塞
  • 螺帽

第十一章 以剂型分類的注射包装市场

  • 液体
    • 多次给药
    • 单一剂量
  • 冻干粉
    • 可复溶粉末
    • 无菌粉末

第十二章：注射包装市场（以灌装量划分）

  • 1-5毫升
  • 5-10毫升
  • 超过10毫升
  • 少于1毫升

第十三章 注射剂药品包装市场：依最终用户划分

  • 门诊治疗
  • 诊所
  • 居家照护
  • 医院
  • 专科诊所

第十四章 注射剂药品包装市场：依应用领域划分

  • 糖尿病
  • 肿瘤学
  • 疫苗

第十五章 注射剂药品包装市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十六章 注射包装市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十七章 注射剂药品包装市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章：美国注射药品包装市场

第十九章：中国注射包装市场

第20章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Becton, Dickinson and Company
  • Corning Incorporated
  • Gerresheimer AG
  • Nipro Corporation
  • Schott AG
  • SGD Pharma SA
  • Shanghai Pharmaceutical Glass Co., Ltd.
  • Stevanato Group SpA
  • Tofflon Science and Technology Co., Ltd.
  • West Pharmaceutical Services, Inc.
  • Wipak Group
Product Code: MRR-035DA3C63703

The Parenteral Products Packaging Market was valued at USD 24.65 billion in 2025 and is projected to grow to USD 26.83 billion in 2026, with a CAGR of 9.97%, reaching USD 47.97 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 24.65 billion
Estimated Year [2026] USD 26.83 billion
Forecast Year [2032] USD 47.97 billion
CAGR (%) 9.97%

A strategic introduction that frames why parenteral product packaging now governs product integrity, regulatory compliance, and supply chain resilience across modern therapeutic portfolios

The packaging of parenteral products sits at the intersection of patient safety, sterile manufacturing, and global supply chain complexity, and the introduction frames why this domain demands continuous strategic attention. As therapies evolve toward biologics, combination products, and sensitive formulations, packaging has moved beyond containment to become an active enabler of product integrity, sterility assurance, cold chain compatibility, and user-centric dose delivery. Consequently, stakeholders across pharmaceutical development, contract manufacturing, and distribution must align design controls, regulatory pathways, and procurement strategies to preserve therapeutic performance and mitigate contamination risk.

Furthermore, an introduction to this landscape highlights the converging forces of regulatory tightening, material innovation, and customer expectations that compel organizations to revisit legacy packaging platforms. Transitioning from descriptive to prescriptive practice involves translating requirements into validated processes, adopting advanced secondary and tertiary protection measures, and investing in robust supplier qualification programs. In turn, these changes shape capital allocation, operational priorities, and cross-functional collaboration across quality, regulatory, and supply chain teams.

Recent transformative shifts within parenteral packaging reflect a rapid realignment of priorities that extend from raw material sourcing to final dose delivery, catalyzed by technological, regulatory, and commercial drivers. Notably, material science advances have accelerated adoption of polymeric alternatives and engineered glass formulations that reduce delamination risk and improve breakage resistance. At the same time, the industry is experiencing a surge in demand for user-friendly delivery systems and compact formats that support ambulatory and home care administration, prompting suppliers and developers to re-evaluate container geometries, closure interfaces, and compatibility testing.

Transitioning toward more resilient supply networks, manufacturers increasingly pursue supplier diversification and regional sourcing, reducing single-source dependencies that previously contributed to disruption. In parallel, regulatory agencies are emphasizing human factors, extractables and leachables, and container closure integrity testing, which together raise the technical bar for packaging qualification. Consequently, companies investing in automation, closed-system filling, and stringent environmental controls are gaining operational advantages. These cumulative shifts are driving a more integrated view of packaging as a cross-disciplinary enabler of product safety, patient experience, and commercial differentiation.

Assessment of how recent United States tariff dynamics are altering sourcing choices, cost considerations, and nearshoring strategies across the parenteral packaging value chain

The imposition of tariffs and trade policy adjustments originating from the United States has introduced a new layer of cost, timing, and sourcing considerations for organizations that depend on globally sourced packaging components. In response, procurement teams are recalibrating supplier strategies to mitigate tariff exposure by increasing local sourcing, negotiating longer-term contracts with protective terms, and engaging in tariff classification reviews to ensure accurate harmonized system coding. These measures, taken together, help reduce unexpected duty liabilities and enable smoother customs interactions.

Moreover, tariffs have encouraged some manufacturers to localize critical production steps or enter strategic partnerships with regional converters to preserve price competitiveness and reduce lead times. While supply chain reshoring can enhance responsiveness, it also necessitates investment in quality systems and compliance capabilities in new geographies. Consequently, regulatory alignment, workforce training, and capital investment are essential to realize the operational benefits of nearshoring. Ultimately, the cumulative impact of tariff dynamics compels a more holistic cost-to-serve analysis that weighs duty exposure against inventory, lead time, and regulatory conformity.

Detailed segmentation insights revealing how container types, materials, closures, dosage forms, fill volumes, user settings, and applications collectively dictate packaging decisions and testing needs

A nuanced understanding of segmentation reveals where technical requirements, procurement priorities, and clinical use cases intersect to drive packaging decisions. Based on container type, stakeholders evaluate tradeoffs among ampoule, bag, cartridge, syringe, and vial configurations with respect to dosing accuracy, aseptic fill line compatibility, and patient administration needs. In tandem, container material distinctions between glass and plastic require careful consideration; plastic alternatives such as PET, polypropylene, and PVC present diverse benefits and challenges in chemical compatibility, sterilization tolerance, and barrier properties. These material selections must be balanced against regulatory expectations and compatibility testing outcomes.

Closures also play a pivotal role; crimp caps, flip-off caps, rubber stoppers, and screw caps each introduce distinct integrity profiles and aseptic handling requirements, which in turn affect closure selection for specific formulations and fill lines. The dosage form further stratifies packaging approaches as liquid preparations and lyophilized powder demand different containment and reconstitution strategies. Liquid presentations may be designed for multi-dose or single-dose use, while lyophilized powders appear as reconstitutable powder or sterile powder, each imposing unique container closure integrity criteria and reconstitution compatibility. Fill volume categories ranging from up to 1 milliliter through 1 to 5 milliliters, 5 to 10 milliliters, and above 10 milliliters influence fill accuracy, vial geometry, and secondary packaging dimensions. Finally, the end user environment-spanning ambulatory care, clinic, home care, hospital, and specialty clinics-shapes decisions around ease of use, dosing safety features, and portability. Application-specific demands for diabetes, oncology, and vaccines create additional layers of technical and regulatory requirements, which ultimately guide the selection and validation of integrated packaging systems.

Comparative regional perspectives on how supply chain structure, regulatory frameworks, and innovation priorities differ across the Americas, Europe Middle East & Africa, and Asia-Pacific

Regional dynamics exert powerful influence on supply chain configuration, regulatory alignment, and innovation priorities across parenteral packaging. In the Americas, manufacturers and converters often prioritize speed to market, scale manufacturing capability, and regulatory familiarity with local agencies, while also exploring regional partnerships to shorten supply lines. This region's combination of established pharmaceutical clusters and advanced logistics infrastructure supports a focus on efficient distribution and rigorous quality systems.

In Europe, the Middle East & Africa, regulatory complexity and cross-border trade rules encourage harmonized testing protocols and a strong emphasis on sustainability and circularity in packaging decisions. Suppliers in this region increasingly respond to regulatory emphasis on environmental impact by developing recyclable or reduced-material solutions. Meanwhile, in the Asia-Pacific market, rapid capacity expansion, cost-competitive manufacturing, and accelerating adoption of biologics drive demand for scalable sterile filling, contract manufacturing, and high-volume component production. Across regions, transitional themes such as supplier diversification, regional qualification programs, and alignment of quality management systems underscore the need for multinational organizations to adopt flexible sourcing and compliance strategies that are appropriate for local regulatory environments.

Key company-level insights into how suppliers and manufacturers are building competitive advantage through technical investment, integrated services, and resilient partnership models

Leading organizations across the parenteral packaging ecosystem are differentiating through targeted investments in quality, automation, and materials science while forging strategic collaborations to address capability gaps. Suppliers that emphasize closed-system filling and container closure integrity testing are meeting heightened customer expectations for sterility assurance. Concurrently, companies that develop polymer formulations or surface treatments to mitigate delamination and extractables are gaining technical leadership in high-value biologic applications.

Partnership models are evolving; contract manufacturers and component suppliers increasingly offer integrated services that bundle design support, regulatory documentation assistance, and stability testing to shorten development timelines. At the same time, procurement teams are placing greater emphasis on supplier transparency, track-and-trace capabilities, and dual-sourcing arrangements to preserve continuity of supply. Collectively, these behaviors indicate an industry moving toward collaborative value chains where technical competence, regulatory readiness, and operational resilience determine competitive advantage.

Actionable recommendations for industry leaders to strengthen supplier qualification, technical validation, scalability, and sustainability across parenteral packaging operations

Industry leaders can take decisive actions to future-proof packaging strategies by integrating cross-functional priorities into a coherent roadmap that balances innovation with compliance. First, organizations should prioritize end-to-end supplier qualification that includes audit-ready documentation, material verification protocols, and contingency sourcing plans; aligning quality, procurement, and regulatory teams reduces the risk of supply interruptions and expedites corrective actions. Second, investment in enhanced compatibility testing for extractables and leachables, container closure integrity, and human factors will de-risk product launches and support regulatory submissions. These technical investments pay dividends when therapies move from clinical stages to commercial supply.

In addition, companies should pursue design-for-manufacturability practices that shorten fill-finish validation cycles and adopt modular automation to scale production efficiently. Firms must also consider sustainability pathways, such as material-lightening, recyclable components, and energy-efficient processes, to meet stakeholder expectations and regulatory trends. Finally, leaders should cultivate strategic partnerships with converters and contract manufacturers that offer co-development capabilities and flexible regional footprints; this approach enables faster response to policy shifts, tariffs, or demand variability while preserving compliance and quality.

Transparent research methodology explaining the integrated qualitative, technical literature, and best-practice review process that underpins the report's conclusions and recommendations

This research synthesis is grounded in a multi-method approach that integrates primary qualitative inquiry, laboratory protocol review, and secondary technical literature to produce actionable insights. Primary engagement included structured interviews and workshops with quality assurance, regulatory, and procurement professionals to surface operational challenges, supplier selection criteria, and commercialization constraints. These firsthand perspectives were triangulated with technical whitepapers, regulatory guidance documents, and peer-reviewed studies on materials compatibility, container closure integrity, and packaging-related failure modes to ensure technical accuracy.

Complementing stakeholder interviews, a systematic review of industry best practices and case studies informed recommendations around supplier diversification, automation adoption, and testing strategies. Throughout the analysis, methodological rigor was maintained by documenting inclusion criteria for sources, applying reproducible evaluation frameworks to qualitative inputs, and cross-validating conclusions against established regulatory expectations. As a result, the methodology supports robust, defensible insights while remaining adaptable to client-specific inquiries and deeper quantitative investigation when required.

Concluding synthesis that encapsulates how strategic packaging decisions now determine product safety, regulatory readiness, and supply chain robustness across modern therapies

In conclusion, parenteral product packaging is transitioning from a component-centric function to a strategic domain that shapes product viability, regulatory success, and supply continuity. Material innovation, regulatory emphasis on safety and compatibility, and evolving user needs are collectively redefining packaging requirements across the product lifecycle. Organizations that proactively align technical validation, supplier strategy, and operational investments position themselves to mitigate risk and unlock competitive differentiation in an increasingly complex environment.

Looking ahead, the most resilient stakeholders will be those that adopt cross-disciplinary governance, prioritize supplier transparency, and invest in automation and testing capabilities that anticipate regulatory scrutiny. By integrating the recommendations and insights presented, decision-makers can better navigate trade policy shifts, regional variations, and the technical demands of advanced therapies, ensuring packaging decisions are both scientifically sound and operationally sustainable.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Parenteral Products Packaging Market, by Container Type

  • 8.1. Ampoule
  • 8.2. Bag
  • 8.3. Cartridge
  • 8.4. Syringe
  • 8.5. Vial

9. Parenteral Products Packaging Market, by Container Material

  • 9.1. Glass
  • 9.2. Plastic
    • 9.2.1. Pet
    • 9.2.2. Polypropylene
    • 9.2.3. Pvc

10. Parenteral Products Packaging Market, by Closure Type

  • 10.1. Crimp Cap
  • 10.2. Flip Off Cap
  • 10.3. Rubber Stopper
  • 10.4. Screw Cap

11. Parenteral Products Packaging Market, by Dosage Form

  • 11.1. Liquid
    • 11.1.1. Multi Dose
    • 11.1.2. Single Dose
  • 11.2. Lyophilized Powder
    • 11.2.1. Reconstitutable Powder
    • 11.2.2. Sterile Powder

12. Parenteral Products Packaging Market, by Fill Volume

  • 12.1. 1 To 5 Milliliters
  • 12.2. 5 To 10 Milliliters
  • 12.3. Above 10 Milliliters
  • 12.4. Up To 1 Milliliter

13. Parenteral Products Packaging Market, by End User

  • 13.1. Ambulatory Care
  • 13.2. Clinic
  • 13.3. Home Care
  • 13.4. Hospital
  • 13.5. Specialty Clinics

14. Parenteral Products Packaging Market, by Application

  • 14.1. Diabetes
  • 14.2. Oncology
  • 14.3. Vaccines

15. Parenteral Products Packaging Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Parenteral Products Packaging Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Parenteral Products Packaging Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Parenteral Products Packaging Market

19. China Parenteral Products Packaging Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Becton, Dickinson and Company
  • 20.6. Corning Incorporated
  • 20.7. Gerresheimer AG
  • 20.8. Nipro Corporation
  • 20.9. Schott AG
  • 20.10. SGD Pharma SA
  • 20.11. Shanghai Pharmaceutical Glass Co., Ltd.
  • 20.12. Stevanato Group S.p.A.
  • 20.13. Tofflon Science and Technology Co., Ltd.
  • 20.14. West Pharmaceutical Services, Inc.
  • 20.15. Wipak Group

LIST OF FIGURES

  • FIGURE 1. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES PARENTERAL PRODUCTS PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY AMPOULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY AMPOULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY AMPOULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CARTRIDGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CARTRIDGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CARTRIDGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SYRINGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SYRINGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SYRINGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY VIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY VIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY VIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY GLASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY GLASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CRIMP CAP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CRIMP CAP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CRIMP CAP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FLIP OFF CAP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FLIP OFF CAP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FLIP OFF CAP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY RUBBER STOPPER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY RUBBER STOPPER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY RUBBER STOPPER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SCREW CAP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SCREW CAP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SCREW CAP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY MULTI DOSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY MULTI DOSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SINGLE DOSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SINGLE DOSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY RECONSTITUTABLE POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY RECONSTITUTABLE POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY RECONSTITUTABLE POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY STERILE POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY STERILE POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY STERILE POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY 1 TO 5 MILLILITERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY 1 TO 5 MILLILITERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY 1 TO 5 MILLILITERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY 5 TO 10 MILLILITERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY 5 TO 10 MILLILITERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY 5 TO 10 MILLILITERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY ABOVE 10 MILLILITERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY ABOVE 10 MILLILITERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY ABOVE 10 MILLILITERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY UP TO 1 MILLILITER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY UP TO 1 MILLILITER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY UP TO 1 MILLILITER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY AMBULATORY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY AMBULATORY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DIABETES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DIABETES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DIABETES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. GCC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. GCC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. GCC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 212. GCC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 213. GCC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. GCC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 215. GCC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 216. GCC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 217. GCC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 218. GCC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. GCC PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. G7 PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 243. G7 PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. G7 PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 245. G7 PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 246. G7 PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. G7 PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 248. G7 PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 249. G7 PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 250. G7 PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 251. G7 PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. G7 PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. NATO PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 254. NATO PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. NATO PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 256. NATO PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 257. NATO PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. NATO PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 259. NATO PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 260. NATO PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 261. NATO PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 262. NATO PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 263. NATO PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 264. GLOBAL PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES PARENTERAL PRODUCTS PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER TYPE, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CONTAINER MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY CLOSURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LIQUID, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY FILL VOLUME, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 286. CHINA PARENTERAL PRODUCTS PACKAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)